化合物 T10344 T10344
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 151227-08-6 | ¥10,600.00 | 询底价 |
100 mg | 151227-08-6 | ¥17,500.00 | 询底价 |
50 mg | 151227-08-6 | ¥13,800.00 | 询底价 |
Product Introduction
Bioactivity
英文名: AP521
描述: AP521 is an agonist of the human 5-HT1A receptor (IC50: 94 nM).
体外活性: AP521 is an agonist of human 5-HT1A receptor (IC50s: 135, 94, 254, 5530, 418, 422 and 198 nM for 5-HT1A (rat), 5-HT1A (human), 5-HT1B (rat), 5-HT1B (human), 5-HT1D (human), 5-HT5a (human) and 5-HT7 (rat)). AP521 also decreases the forskolin-induced cAMP accumulation from 10 nM to 10 μM.
体内活性: AP521 significantly increases the number of shock acceptances at doses between 0.5 to 10 mg/kg. Oral administration of AP521 at 3 and 10 mg/kg significantly decreases freezing time. AP521 significantly increases the time spent on the open arms by approximately 2-fold as compared to the vehicle-treated group [F(3, 36)=4.21, P<0.05 for AP521]. The anxiolytic-like effect of AP521 appears to be dose-related. AP521 significantly increases the extracellular 5-HT level of the medial prefrontal cortex (mPFC) at 10 mg/kg from 0.5 to 1 h after administration. AP521 at 3 mg/kg tends to increase the extracellular 5-HT level, however, this increase is not significant.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: AP 521 | AP521 | AP-521
相关产品: Protriptyline hydrochloride | RS102895 hydrochloride | Frovatriptan succinate hydrate | Promazine hydrochloride | Vortioxetine hydrobromide | lumateperone Tosylate | Urapidil hydrochloride | Isocorynoxeine | P-Hydroxyphenethyl trans-ferulate | Lesopitron dihydrochloride
化合物 T10344 T10344信息由TargetMol中国为您提供,如您想了解更多关于化合物 T10344 T10344报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途